[{"address1": "900 North Point Parkway", "address2": "Suite 200", "city": "Alpharetta", "state": "GA", "zip": "30005", "country": "United States", "phone": "678 270 3631", "fax": "678 270 4033", "website": "https://clearsidebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.", "age": 72, "title": "President, CEO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 836154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles A. Deignan", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 568676, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jenny R. Kobin", "age": 57, "title": "Head of Investor Relations", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rick  McElheny", "title": "Senior Vice President of Corporate Development & Alliance Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rafael V. Andino", "age": 59, "title": "Senior Vice President of Engineering & Manufacturing", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan L. Coultas Ph.D.", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ngai Hang  Chong FRCOphth, FRCS, M.B.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leslie B. Zacks J.D.", "age": 55, "title": "Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.01, "open": 1.01, "dayLow": 1.01, "dayHigh": 1.07, "regularMarketPreviousClose": 1.01, "regularMarketOpen": 1.01, "regularMarketDayLow": 1.01, "regularMarketDayHigh": 1.07, "beta": 2.222, "forwardPE": -2.4429226, "volume": 112226, "regularMarketVolume": 112226, "averageVolume": 248200, "averageVolume10days": 244870, "averageDailyVolume10Day": 244870, "ask": 1.06, "askSize": 100, "marketCap": 81152552, "fiftyTwoWeekLow": 0.801, "fiftyTwoWeekHigh": 2.12, "priceToSalesTrailing12Months": 10.535188, "fiftyDayAverage": 0.98056, "twoHundredDayAverage": 1.12955, "currency": "USD", "enterpriseValue": 107534552, "floatShares": 70221225, "sharesOutstanding": 75843504, "sharesShort": 777769, "sharesShortPriorMonth": 741677, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.010299999, "heldPercentInsiders": 0.07281, "heldPercentInstitutions": 0.20642, "shortRatio": 5.16, "shortPercentOfFloat": 0.0109, "impliedSharesOutstanding": 78626800, "bookValue": -0.465, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -31878000, "trailingEps": -0.45, "forwardEps": -0.5, "enterpriseToRevenue": 13.96, "enterpriseToEbitda": -4.393, "52WeekChange": -0.21705425, "SandP52WeekChange": 0.22903383, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CLSD", "underlyingSymbol": "CLSD", "shortName": "Clearside Biomedical, Inc.", "longName": "Clearside Biomedical, Inc.", "firstTradeDateEpochUtc": 1464874200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ea57bdfa-5d41-3e30-b431-13e72798980d", "messageBoardId": "finmb_145617165", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.07, "targetHighPrice": 8.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 23591000, "totalCashPerShare": 0.311, "ebitda": -24481000, "totalDebt": 49973000, "quickRatio": 4.359, "currentRatio": 4.49, "totalRevenue": 7703000, "revenuePerShare": 0.109, "returnOnAssets": -0.48458, "grossProfits": 7703000, "freeCashflow": -17203124, "operatingCashflow": -18949000, "revenueGrowth": 0.208, "grossMargins": 1.0, "operatingMargins": -5.71676, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]